Metabolic Exercise Testing

NCT02362685 — Recruiting, 1000 participants, University Hospital, Brest

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Exercise Testing in Metabolic Myopathies

RegistryNCT02362685, acronym RANNOU
StatusRecruiting
Study typeObservational
Enrollment1000 (Estimated)
SponsorUniversity Hospital, Brest (Other)
ConditionsMetabolic Myopathies, Exercise Test, Myalgia
Interventionsfunctional test, matching genotype with phenotype (Device, genetic)
Datesstart 2008-09-01, primary completion 2027-12-01 (estimated), completion 2027-12-01 (estimated), first posted 2015-02-13, last updated 2020-01-22
Locations1 site in France

Related Papers Related Patents Related Grants Related Experts
All trials for Metabolic Myopathies All trials for Exercise Test All trials of functional test All trials of matching genotype with phenotype

-Summary

Exertional symptoms are the hallmarks of metabolic myopathies, supporting the concept of using functional tests when this diagnosis is suspected. Exercise increases the concentration of muscle metabolites in the venous blood supply (e.g. lactate, pyruvate, and ammonia) especially during recovery. The purpose of this study is to compare the results of exercise testing with to the data from muscle biopsy or genetic analysis.

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
metabolic exercise testingDevice: functional test; Genetic: matching genotype with phenotypeAll the subjects referred to performed a metabolic exercise testing.
  • functional test (Device): subjects perform a metabolic exercise testing
  • matching genotype with phenotype (Genetic)

+Outcome measures

Primary outcomes

  • Whole-body dynamic exercise [Participants will be followed for an expected average of 1 year to determine whether a muscle biopsy is performed]: The relation between Cardiopulmonary exercise test variables and the results of muscle biopsy or genetic analysis will be evaluated.
  • Grip-test [Participants will be followed for an expected average of 1 year to determine whether a muscle biopsy is performed]: The relation between Grip-test variables and the results of muscle biopsy or genetic analysis will be evaluated.
  • Blood tests [Participants will be followed for an expected average of 1 year to determine whether a muscle biopsy is performed]: The results of blood analysis from samples performed before, during, and after exercise will be compared to the results of muscle biopsy or genetic analysis.

+Eligibility

Sex: All, ages: 5 Years to any, accepts healthy volunteers

Inclusion Criteria:

* Referred to the Physiology Department of Brest Hospital for a metabolic exercise test
* Ability to provide informed consent

Exclusion Criteria:

* Contraindication(s) to perform cardiopulmonary exercise testing (ATS/ACCP statement on cardiopulmonary exercise testing, Am J respi Care Med 167: 211-77, 2003)
* Pregnancy or unknown pregnancy status.

+Locations (1)

FacilityCityCountryStatus
Centre Hospitalier Régional UniversitaireBrestFranceRecruiting

+Investigators